NCT02247466View on ClinicalTrials.gov

Optimizing Surgical Conditions During Laparoscopic Herniotomy With Deep Neuromuscular Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

February 23, 2017

Study Completion Date

February 23, 2017

Conditions
Laparoscopic Herniotomy
Interventions
DRUG

Rocuronium and Sugammadex

Trial Locations (2)

2730

Herlev Hospital, Herlev

2900

Gentofte Hospital, Hellerup

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT02247466 - Optimizing Surgical Conditions During Laparoscopic Herniotomy With Deep Neuromuscular Blockade | Biotech Hunter | Biotech Hunter